Histological damage in chronic hepatitis C is not related to the extent of infection in the liver.
Rodríguez-Iñigo E, Bartolomé J, de Lucas S, Manzarbeitia F, Pardo M, Arocena C, Gosálvez J, Oliva H,Carreño V. Am J Pathol 1999; 154: 1877-1881.
Sequence variation of hepatitis B virus precore-core open reading frame isolated from serum and liver of children with chronic hepatitis B before and after interferon treatment.
Cabrerizo M, Bartolomé J, Otero M, Ruíz-Moreno M,Carreño V. J Med Virol 1999; 58: 208-214.
ltimos avances en hepatología.
Carreño V.Hepatol Clin1999; 7: 25-42.
Cinética del interferón a-2a en pacientes en hemodiálisis.
Albalate M, Martín J, de Sequera P, Quiroga JA, Olagüe C, Caramelo C,Carreño V.Nefrología 1999; 19: 268-270.
Modulation by biologic response modifiers of hepatitis C virus antigen-independent cytokine secretion in blood mononuclear cells.
Martín J, Quiroga JA, Navas S, Pardo M,Carreño V. Cytokine 1999; 11: 267-273.
Alteraciones de la coagulación en las hepatopatías crónicas.
Manzano ML, Arocena C, Quiroga JA,Carreño V.Rev Iber Tromb Hem 1999; 12: 38-40
ltimos avances en hepatología.
Carreño V.Hepatol Clin1999; 7: 171-206.
In vitro infection of human peripheral blood mononuclear cells by GB virus C/hepatitis G virus
Fogeda M, Navas S, Martín J, Casqueiro M, Rodríguez E, Arocena C,Carreño V. J Virol 1999; 73: 4052-4061.
ltimos avances en hepatología.
Carreño V, Castillo I.Hepatol Clin1999; 7: 125-150.
Transplantation of allogeneic CD34-selected peripheral stem cells does not prevent transmission of hepatitis C virus from an infected donor.
Tomás JF, Rodríguez-Iñigo E, Bartolomé J, Alegre A, Fernández-Rañada JM,Carreño V. Bone Marrow Transplant 1999; 24: 109-112.
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C
Zeuzem S, Hopf U,Carreño V, Diago M, Shiffman M, Grüne S, Dudley FJ, Rakhit A, Rittweger K, Yap SH, Koff RS, Thomas HC. Hepatology 1999; 29: 1280-1287.
In vitro effect of amantadine and interferon alpha 2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus infected patients.
Martín J, Navas S, Fernández M, Rico M, Pardo M, Quiroga JA, Zahm F,Carreño V. Antiviral Res 1999; 42: 59-70.
